Infimer Financials
| INFR Stock | ILA 1.50 24,498 99.99% |
Infimer |
Understanding current and past Infimer Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Infimer's financial statements are interrelated, with each one affecting the others. For example, an increase in Infimer's assets may result in an increase in income on the income statement.
Please note, the presentation of Infimer's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Infimer's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Infimer's management manipulating its earnings.
Infimer Stock Summary
Infimer competes with Hiron Trade, One Software, Analyst IMS, Aura Investments, and Discount Investment. Infimer Ltd develops technology and production processes for converting municipal solid waste. The company was founded in 2013 and is based in Avihayil, Israel. INFIMER operates under Waste Management classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 23700 people.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0010806888 |
| Business Address | 6 Hashomer Street, |
| Sector | Chemicals |
| Industry | Materials |
| Benchmark | Dow Jones Industrial |
| Website | www.infimer.com |
| Phone | 972 73 700 0266 |
| Currency | ILA |
You should never invest in Infimer without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Infimer Stock, because this is throwing your money away. Analyzing the key information contained in Infimer's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Infimer Key Financial Ratios
Infimer's financial ratios allow both analysts and investors to convert raw data from Infimer's financial statements into concise, actionable information that can be used to evaluate the performance of Infimer over time and compare it to other companies across industries.| Return On Asset | -0.33 | |||
| Beta | 1.52 | |||
| Z Score | 37.2 | |||
| Last Dividend Paid | 589.96 |
Infimer Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Infimer's current stock value. Our valuation model uses many indicators to compare Infimer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Infimer competition to find correlations between indicators driving Infimer's intrinsic value. More Info.Infimer is rated second overall in return on asset category among its peers. It also is rated second overall in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Infimer by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Infimer's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Infimer Systematic Risk
Infimer's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Infimer volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Infimer correlated with the market. If Beta is less than 0 Infimer generally moves in the opposite direction as compared to the market. If Infimer Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Infimer is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Infimer is generally in the same direction as the market. If Beta > 1 Infimer moves generally in the same direction as, but more than the movement of the benchmark.
Infimer November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Infimer help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Infimer. We use our internally-developed statistical techniques to arrive at the intrinsic value of Infimer based on widely used predictive technical indicators. In general, we focus on analyzing Infimer Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Infimer's daily price indicators and compare them against related drivers.
| Downside Deviation | 51.48 | |||
| Information Ratio | 0.2292 | |||
| Maximum Drawdown | 1099.99 | |||
| Value At Risk | (99.99) | |||
| Potential Upside | 1000.0 |
Complementary Tools for Infimer Stock analysis
When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |